Premium
Pentoxifylline‐tocopherol‐clodronate combination: A novel treatment for osteoradionecrosis of the temporal bone
Author(s) -
Glicksman Jordan T.,
Khalili Sammy,
Fung Kevin,
Parnes Lorne S.,
Agrawal Sumit K.
Publication year - 2015
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.24057
Subject(s) - osteoradionecrosis , pentoxifylline , medicine , radiation therapy , temporal bone , complication , surgery , head and neck , radiology
Background Osteoradionecrosis (ORN) of the temporal bone is a complication of radiation therapy that is extremely challenging to manage. Methods We report the case of a patient treated at our institution and present a review of the literature. Results A 52‐year‐old woman presented with ORN of the temporal bone 20 years after radiation therapy for an ipsilateral parotid tumor. She failed conservative management, including serial debridements, oral and topical antibiotics/antifungals, and aural lavage. As an alternative to hyperbaric oxygen (HBO) and/or temporal bone resection, treatment with pentoxifylline‐tocopherol‐clodronate combination (PENTOCLO) was pursued and her condition improved dramatically. Conclusion This is the first document use of PENTOCLO to treat ORN of the temporal bone. PENTOCLO may represent an effective nonsurgical management option for ORN of the temporal bone. © 2015 Wiley Periodicals, Inc. Head Neck 37: E191–E193, 2015